Why Tactile Systems Technology Stock Surged by Nearly 18% Today
Key Points
The medical devices specialist posted its final set of figures for 2025.
In the fourth quarter, it grew both revenue and profitability at impressive rates.
- 10 stocks we like better than Tactile Systems Technology ›
Next-generation medical device company Tactile Systems Technology (NASDAQ: TCMD) was the very picture of health on Wednesday, at least as far as its stock was concerned. Investors bid up the company's shares robustly, by nearly 18%, thanks to an impressive earnings report.
Healthy increases
Just after market close on Tuesday, Tactile published its fourth quarter and full-year 2025 figures. The company's total revenue rose by a sturdy 21% to $103.6 million, and net income in accordance with generally accepted accounting principles (GAAP) increased by 9% to $10.6 million ($0.46 per share).
Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue »
Image source: Getty Images.
Both headline numbers beat the average analyst estimates. Prognosticators following Tactile were collectively expecting the company to post revenue below $94 million and per-share profit of $0.44.
Tactile attributed the considerable revenue gain, in part, to a 66% increase in sales of its airway clearance products. It also recorded a 16% rise in both sales and rentals of its devices for treating lymphedema, a disorder of the body's lymphatic system.
Good guidance
Investors were also cheered by Tactile's rather bullish guidance for the entirety of 2026. Management is expecting revenue to grow by 8% to 11% over the 2025 figure, specifically to $357 million to $365 million. This should shake out into a non-GAAP (adjusted) earnings before interest, taxes, depreciation, and amortization (EBITDA) number between $49 million $51 million. This would compare favorably to 2025's $44.8 million.
I see almost nothing to dislike in both Tactile's quarter and its full-year 2025 results. The company has found more than one niche in which to thrive, and it is clearly effective at selling to those segments. Meanwhile, the medical device market is set to grow robustly, as the population ages and technology improves medical care. I'd consider buying Tactile's stock.
Should you buy stock in Tactile Systems Technology right now?
Before you buy stock in Tactile Systems Technology, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Tactile Systems Technology wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $415,256!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,133,904!*
Now, it’s worth noting Stock Advisor’s total average return is 889% — a market-crushing outperformance compared to 193% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
See the 10 stocks »
*Stock Advisor returns as of February 18, 2026.
Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
Recommended Articles
